What is AnimalBiome?
Founded in 2016 and based in Oakland, California, AnimalBiome leverages advanced genetic sequencing to analyze the gut microbiome of pets. By characterizing the unique microbial composition of individual animals, the company enables veterinarians and pet owners to implement tailored dietary adjustments, including prebiotics and specific macronutrient ratios. These personalized nutrition plans aim to foster a balanced gut bacteria environment, thereby enhancing overall pet well-being. AnimalBiome also develops restorative supplements derived from healthy pet sources to address digestive issues and restore microbial equilibrium. The company's foundation is rooted in research from the University of California, Davis, positioning it at the forefront of scientific innovation in pet wellness.
How much funding has AnimalBiome raised?
AnimalBiome has raised a total of $10.1M across 2 funding rounds:
Angel/Seed
$1.5M
Series A
$8.6M
Angel/Seed (2020): $1.5M, investors not publicly disclosed
Series A (2021): $8.6M led by Digitalis Ventures, R/GA, SOSV, Cargill, and Moai Capital Group
Key Investors in AnimalBiome
Digitalis Ventures
Digitalis Ventures engineers solutions to unmet needs in health by leveraging deep technical, financial, and domain expertise. The company invests in biotechnology and technology-enabled solutions aimed at improving human and animal health while reducing costs. Their multidisciplinary team focuses on creatively financing, building, and scaling enduring enterprises.
Cargill
Cargill Meat Solutions Corporation is a leading processor and distributor of fresh beef, pork and turkey, plus cooked and marinated meats. Representing more than a dozen major brands that are sold in both retail and foodservice channels, Cargill Meat Solutions is committed to providing great-tasting meat to our customers and consumers around the world.
SOSV
SOSV is a multi-stage venture capital investor that provides intellectual and financial capital to accelerate founders big ideas.
What's next for AnimalBiome?
With its recent major strategic investment, AnimalBiome is poised for accelerated expansion and further development of its microbiome-based pet health solutions. The enterprise-level capital infusion will likely support scaling operations, enhancing research and development capabilities, and broadening market reach. This strategic financing suggests a focus on solidifying its position as a leader in the pet microbiome diagnostics and personalized nutrition market, potentially exploring new product lines or expanding into adjacent pet wellness categories. The company's trajectory indicates a strong commitment to advancing veterinary science and improving the lives of pets through data-driven, personalized interventions.
See full AnimalBiome company page
